Coverage
-
June 17, 2016
A Florida federal judge sorting out Greenspoon Marder's fight for litigation costs from a nearly $1.8 million securities fraud case against a GlaxoSmithKline unit ruled Thursday that the firm’s bid for roughly $560,000 “grossly exceeds” the “reasonable and necessary” amount it is entitled to after a pretrial withdrawal.
4 other articles on this case.
View all »